CD14 and melanoma: In melanoma, miR-146a was responsible for the conversion of monocytes into MDSC (CD14 + HLA-DR neg cells) mediated by melanoma extracellular vesicles and were shown to recreate MDSC features upon transfection [34], suggesting that its levels can influence the fine-tuning of pro- or anti-inflammatory pathways, depending on the cell type.